Canadian IBD Research Consortium[Corporate Author] - Search Results

Year	Number of Results
2022	1
2023	4
2024	5

1

REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study.

Ma C, Panaccione R, Xiao Y, Khandelwal Y, Murthy SK, Wong ECL, Narula N, Tsai C, Peerani F, Reise-Filteau M, Bressler B, Starkey SY, Loomes D, Sedano R, Jairath V, Bessissow T; Canadian IBD Research Consortium. Ma C, et al. Am J Gastroenterol. 2023 May 1;118(5):861-871. doi: 10.14309/ajg.0000000000002129. Epub 2022 Dec 14. Am J Gastroenterol. 2023. PMID: 36580497 Free PMC article.

2

Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.

McCurdy JD, Munir J, Parlow S, Reid J, Yanofsky R, Alenezi T, Meserve J, Becker B, Lahijanian Z, Eddin AH, Mallick R, Ramsay T, Rosenfeld G, Bessissow A, Bessissow T, Jairath V, Singh S, Bruining DH, Macdonald B; Canadian IBD Research Consortium. McCurdy JD, et al. Clin Gastroenterol Hepatol. 2024 May;22(5):1058-1066.e2. doi: 10.1016/j.cgh.2023.12.006. Epub 2023 Dec 18. Clin Gastroenterol Hepatol. 2024. PMID: 38122958

3

Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study.

Bessissow T, Narula N, Ma C, In TSH, Eberg M, Karra K, Jairath V; Canadian IBD Research Consortium. Bessissow T, et al. Dig Liver Dis. 2024 Jan;56(1):61-69. doi: 10.1016/j.dld.2023.08.042. Epub 2023 Sep 15. Dig Liver Dis. 2024. PMID: 37716860

4

Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement.

Narula N, Hamam H, Peerani F, Bessissow T, Bressler B, Dulai PS; Canadian IBD Research Consortium. Narula N, et al. Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002860. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38775974

5

Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease.

Bessissow T, Narula N, Ma C, In TSH, Pone E, Eberg M, Jairath V; Canadian IBD Research Consortium. Bessissow T, et al. Dig Liver Dis. 2024 May 30:S1590-8658(24)00718-7. doi: 10.1016/j.dld.2024.04.017. Online ahead of print. Dig Liver Dis. 2024. PMID: 38821813

6

Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease.

Murthy SK, Bernstein CN, Nguyen GC, Jairath V, Riddell R, Fergusson D; Canadian IBD Research Consortium. Murthy SK, et al. Clin Gastroenterol Hepatol. 2024 Jul;22(7):1535-1538.e2. doi: 10.1016/j.cgh.2023.12.007. Epub 2023 Dec 18. Clin Gastroenterol Hepatol. 2024. PMID: 38122957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year